The use of cathepsin-targeted NIR FI during breast cancer surgery could help to identify residual tumor on the surgical cavity surfaces and guide additional excision, thereby minimizing tumor-positive margins, the need for re-resection, and local recurrence (Fig. 1). This evidence concerns the gene CTSS and breast cancer.